Literature DB >> 17531027

Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.

Manal F Abdelmalek, Chen Liu, John F Valentine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17531027     DOI： 10.1111/j.1572-0241.2007.01131.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

1.  Treatment of chronic hepatitis C in patients with Crohn's disease.

Authors:  Jill Gaidos; Virginia Clark; John F Valentine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

2.  Concomitant therapy of Crohn's disease and hepatitis C with budesonide and antivirals.

Authors:  Alok Gupta; Michael D Sitrin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

3.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

4.  A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 5.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

Authors:  Alina M Allen; W Ray Kim; Joseph Larson; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

Review 7.  The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease.

Authors:  Ming Valerie Lin; Wojciech Blonski; Anna M Buchner; K Rajender Reddy; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2012-11-20       Impact factor: 3.199

Review 8.  Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.

Authors:  Maurizio Pompili; Marco Biolato; Luca Miele; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.